• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatology  • Dermatologic Disorders  • Quality of Life  • Renal Diseases  • Renal Diseases, Other  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Alert me on articles by topic  Social Bookmarking   What's this?

Late Skin Manifestations

Nannie Bangsgaard, MD; Peter Marckmann, MD, DMSc; Kristian Rossen, MD; Lone Skov, MD, DMSc

Arch Dermatol. 2009;145(2):183-187.

Background  Nephrogenic systemic fibrosis (NSF) is a serious disease that occurs in patients with severe renal disease and is believed to be caused by gadolinium-containing contrast agents. A detailed description of the late skin manifestations of NSF is important to help dermatologists and nephrologists recognize the disease.

Observations  We studied 17 patients with NSF late in the disease. All patients showed epidermal atrophy and hairlessness of the affected regions, primarily the lower legs. Affected areas were symmetrically distributed and hyperpigmented in most cases. Eleven patients showed confluent dermal plaques with thickening and hardening. In contrast, 3 patients presented with wrinkled, redundant skin as seen in cutis laxa. Patients with NSF had significantly poorer scores than control patients on the Daily Life Quality Index (mean [SD], 11. 4 [7.4] vs 1.5 [2. 3]; P < .001).

Conclusions  This descriptive case series of patients with NSF gives a detailed clinical picture of the skin manifestations late in the disease. It demonstrates that the clinical picture in the late stage has a varied presentation and that NSF has a significant effect on the quality of life.

Author Affiliations: Departments of Dermatology (Drs Bangsgaard and Skov) and Pathology (Dr Rossen), University Hospital of Copenhagen Gentofte, Hellerup, and Department of Nephrology, University Hospital of Copenhagen Herlev, Herlev (Dr Marckmann), Denmark. Dr Marckmann is now with the Department of Nephrology, Odense University Hospital, Odense, Denmark.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Dermatology
Arch Dermatol. 2009;145(2):119.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Two cases of nephrogenic systemic fibrosis after exposure to the macrocyclic compound gadobutrol
Elmholdt et al.
Clin Kidney J 2010;3:285-287.
ABSTRACT | FULL TEXT  

Nephrogenic systemic fibrosis
Burge and Wallis
Oxford Handbook of Medical Dermatology 2010;1:med-9780199558322-div1-02-med-9780199558322-div1-02.
FULL TEXT